Juhlin CC - Search Results

1

Absence of KMT2D/MLL2 mutations in abdominal paraganglioma.

Stenman A, Juhlin CC, Haglund F, Brown TC, Clark VE, Svahn F, Bilguvar K, Goh G, Korah R, Lifton RP, Carling T. Stenman A, et al. Among authors: juhlin cc. Clin Endocrinol (Oxf). 2016 Apr;84(4):632-4. doi: 10.1111/cen.12884. Epub 2015 Sep 22. Clin Endocrinol (Oxf). 2016. PMID: 26303934 No abstract available.

2

Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression.

Carling T, Rastad J, Ridefelt P, Gobl A, Hellman P, Oberg K, Rask L, Larsson C, Juhlin C, Akerström G, et al. Carling T, et al. Surgery. 1995 Dec;118(6):924-30; discussion 930-1. doi: 10.1016/s0039-6060(05)80095-9. Surgery. 1995. PMID: 7491535

3

Regulation of gp330/megalin expression by vitamins A and D.

Liu W, Yu WR, Carling T, Juhlin C, Rastad J, Ridefelt P, Akerström G, Hellman P. Liu W, et al. Eur J Clin Invest. 1998 Feb;28(2):100-7. doi: 10.1046/j.1365-2362.1998.00253.x. Eur J Clin Invest. 1998. PMID: 9541123

4

Vitamin D receptor gene polymorphism and parathyroid calcium sensor protein (CAS/gp330) expression in primary hyperparathyroidism.

Carling T, Ridefelt P, Hellman P, Juhlin C, Lundgren E, Akerström G, Rastad J. Carling T, et al. World J Surg. 1998 Jul;22(7):700-6; discussion 706-7. doi: 10.1007/s002689900456. World J Surg. 1998. PMID: 9606285

5

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.

Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenström J, Forsberg L, Bränström R, Obara T, Arnold A, Larsson C, Höög A. Juhlin CC, et al. Endocr Relat Cancer. 2007 Jun;14(2):501-12. doi: 10.1677/ERC-07-0021. Endocr Relat Cancer. 2007. PMID: 17639063

6

Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.

Juhlin CC, Haglund F, Villablanca A, Forsberg L, Sandelin K, Bränström R, Larsson C, Höög A. Juhlin CC, et al. Int J Oncol. 2009 Feb;34(2):481-92. Int J Oncol. 2009. PMID: 19148484

7

Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.

Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenström J, Höög A, Larsson C. Juhlin CC, et al. PLoS One. 2010 Mar 1;5(3):e9472. doi: 10.1371/journal.pone.0009472. PLoS One. 2010. PMID: 20208994 Free PMC article.

8

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

Juhlin CC, Nilsson IL, Johansson K, Haglund F, Villablanca A, Höög A, Larsson C. Juhlin CC, et al. Endocr Pathol. 2010 Sep;21(3):166-77. doi: 10.1007/s12022-010-9121-z. Endocr Pathol. 2010. PMID: 20473645

9

Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas.

Haglund F, Andreasson A, Nilsson IL, Höög A, Larsson C, Juhlin CC. Haglund F, et al. Among authors: juhlin cc. Clin Endocrinol (Oxf). 2010 Oct;73(4):552-3. doi: 10.1111/j.1365-2265.2010.03830.x. Clin Endocrinol (Oxf). 2010. PMID: 20550535 No abstract available.

10

Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours.

Juhlin CC, Haglund F, Obara T, Arnold A, Larsson C, Höög A. Juhlin CC, et al. Virchows Arch. 2011 Jul;459(1):47-53. doi: 10.1007/s00428-010-1032-3. Epub 2011 Jan 8. Virchows Arch. 2011. PMID: 21221636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page